Paolo Gresele, Gustav V. R Born, Carlo Patrono, Clive P. Page
Springer Science & Business Media, Aug 23, 2012 - Medical - 616 pages
Antiplatelet therapy is the cornerstone of treatment of ischemic cardiovascular disease and over the last few years spectacular advancements in this field have been recorded. This is the first comprehensive handbook entirely dedicated to all the aspects of antiplatelet therapy. The book is divided into three main sections, pathophysiology, pharmacology and therapy, for a total of 23 chapters. A large group of leading experts from different European countries and from the USA, both from academia and industry, have contributed to the book. Besides a detailed overview on the pharmacology and clinical applications of all the currently used or of the novel antiplatelet agents, innovative approaches (e.g. intracellular signalling as an antiplatelet target, small RNAs as platelet therapeutics, etc.) or unconventional aspects (e.g. pharmacologic modulation of the inflammatory action of platelets are also treated. The book is oriented to both basic investigators and to clinicians involved with research on platelet inhibition or with the clinical use of antiplatelet therapies.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Other editions - View all
abciximab acute coronary syndromes agonists aIIbb3 antagonists antibody antiplatelet agents antiplatelet drugs antiplatelet therapy antithrombotic artery disease aspirin associated atherosclerotic binding Biol Chem bleeding Blood cardiovascular events cilostazol Circulation Clin clinical clopidogrel Coll Cardiol collagen collagen receptor diabetes dipyridamole domain effect efficacy end point endothelial cells Engl eptifibatide extracellular fibrinogen gene genetic glycoprotein IIb/IIIa GPIba GPIIb/IIIa GPVI human platelets increased integrin interaction ischemic stroke kinase ligand loading dose mediated megakaryocytes membrane meta-analysis mg daily mice miRNA molecules myocardial infarction outcomes P-selectin P2Y12 receptor pathways Patrono percutaneous coronary intervention phosphorylation placebo plasma platelet activation platelet adhesion platelet aggregation platelet function platelet inhibition platelet response prasugrel prevention primary proplatelet protein randomised randomized reduced risk role signaling stent target thienopyridines Thromb Haemost thrombin thrombosis thrombotic thromboxane thrombus formation ticagrelor ticlopidine tirofiban treatment trial TXA2 variability vivo von Willebrand factor Willebrand factor